Further, in recovered COVID-19 patients, Agerer et al. (18) confirmed that single mutations in CD8+ T-cell epitopes led to diminished HLA-I binding, a weaker T-cell response, and ineffective cytotoxicity in HLA-matched COVID-19 patients. The gene discussed is CD8A; the disease is COVID-19.